No insinuation at all, just a statement of fact. The following is extracted from Note 2 to the accounts:
FY19
1H20
1
A$m
A$m
2
Group Revenue
264.1
220.3
3
4
Segmental EBITDA
63.8
27.9
5
Corporate Costs
35.1
21.2
6
EBITDA (exc significant items)
28.7
6.7
7
8
ANZ Revenue
196.8
135.2
9
ANZ Segmental EBITDA
87.0
63.6
10
Corporate Costs Allocation*
26.2
13.0
11
ANZ EBITDA (exc signif items)
60.8
50.6
12
ANZ EBITDA Margin
30.9%
37.4%
13
14
US Revenue
39.0
56.6
15
US Segmental EBITDA
-24.6
-30.7
16
Corporate Costs Allocation*
5.2
5.4
17
US EBITDA (exc signif items)
-29.8
-36.1
18
US EBITDA Margin
19
20
ROW Revenue
11.2
20.4
21
ROW Segmental EBITDA
-3.5
-7.7
22
Corporate Costs Allocation*
1.5
2.0
23
ROW EBITDA (exc signif items)
-5.0
-9.7
24
ANZ EBITDA Margin
25
26
Pay Now Revenue
17.1
8.1
27
Pay Now Segmental EBITDA
4.9
2.7
28
Corporate Costs Allocation*
2.3
0.8
29
Pay Now EBITDA (exc signif items)
2.6
1.9
30
Pay Now EBITDA Margin
15.4%
23.7%
* Corporate Costs allocated in the same ratio as contribution to Group Revenue
As you can see, in 1H20 ANZ EBITDA (before significant items and share based payments) was $50.6m. My expectation is it will be ~$110m for the full year.
APT Price at posting:
$72.50 Sentiment: Hold Disclosure: Held